| Literature DB >> 32075526 |
Frida Ben-Ami1, Christian Orlic2, Roland R Regoes3.
Abstract
Exposure to a pathogen primes many organisms to respond faster or more efficiently to subsequent exposures. Such priming can be non-specific or specific, and has been found to extend across generations. Disentangling and quantifying specific and non-specific effects is essential for understanding the genetic epidemiology of a system. By combining a large infection experiment and mathematical modelling, we disentangle different transgenerational effects in the crustacean model Daphnia magna exposed to different strains of the bacterial parasite Pasteuria ramosa. In the experiment, we exposed hosts to a high dose of one of three parasite strains, and subsequently challenged their offspring with multiple doses of the same (homologous) or a different (heterologous) strain. We find that exposure of Daphnia to Pasteuria decreases the susceptibility of their offspring by approximately 50%. This transgenerational protection is not larger for homologous than for heterologous parasite challenges. Methodologically, our work represents an important contribution not only to the analysis of immune priming in ecological systems but also to the experimental assessment of vaccines. We present, for the first time, an inference framework to investigate specific and non-specific effects of immune priming on the susceptibility distribution of hosts-effects that are central to understanding immunity and the effect of vaccines.Entities:
Keywords: Daphnia magna; Pasteuria ramosa; host heterogeneity; immune priming; mathematical modelling; trained immunity
Mesh:
Year: 2020 PMID: 32075526 PMCID: PMC7031663 DOI: 10.1098/rspb.2019.2386
Source DB: PubMed Journal: Proc Biol Sci ISSN: 0962-8452 Impact factor: 5.349
Figure 1.Design of our experiment. Mother Daphnia were exposed to three different strains of Pasteuria ramosa, P1, P2, or P5. A control cohort of mother Daphnia was not exposed. The offspring of these mothers were then exposed to seven different challenge doses of P1, P2, or P5. The sample sizes for each group are indicated on the diagram. They amount to approximately 20–30 individuals per strain and challenge dose. In total, we used 2567 individuals. (Online version in colour.)
Figure 2.Fraction of infected hosts versus parasite challenge dose for each maternal treatment group. The colour and line type scheme is chosen in concordance with the experimental design schematic shown in figure 1. For a figure showing these data by offspring parasite, see electronic supplementary material, figure S2. (Online version in colour.)
Model variants considered in the model selection scheme. The highlighted r − m model has the strongest statistical support.
Figure 3.Model selection scheme. The thick arrows denote statistically significant model improvements. Statistical significance was determined by a likelihood ratio test between two models. The p-values of these tests are shown. The thick ellipse circles the most complex model with statistical support.
Figure 4.ID50 by maternal treatment group. Vertical bars show the standard error of the ID50 estimates that were calculated by bootstrap (see electronic supplementary material). (Online version in colour.)